PopulationsIn silico

Co-occurrence patterns and related risk factors of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease

Fig. 1. Global distribution of the incidence of T2DM (A) and MASLD (B), and characteristics of co-occurrence in the incidence of T2DM and MASLD (C).
Open the figure at full size
Fig. 1. Global distribution of the incidence of T2DM (A) and MASLD (B), and characteristics of co-occurrence in the incidence of T2DM and MASLD (C).Global distribution of the incidence of T2DM (A) and MASLD (B), and characteristics of co-occurrence in the incidence of T2DM and MASLD (C).Pan et al. · CC BY-NC-ND

Endocrine

The paper

Second Affiliated Hospital of Zhejiang University

Endocrine · 26 Sep 2026 · CC BY-NC-ND

doi.org/10.1007/s12020-026-04810-5PubMed 42799817

More on Type 2 diabetes